Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $17.58 in the prior trading day, Hims & Hers Health Inc (NYSE: HIMS) closed at $17.84, up 1.48%. In other words, the price has increased by $1.48 from its previous closing price. On the day, 20.74 million shares were traded. HIMS stock price reached its highest trading level at $18.075 during the session, while it also had its lowest trading level at $15.87.
Ratios:
Our goal is to gain a better understanding of HIMS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 73.83. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on May 22, 2024, Downgraded its rating to Neutral and sets its target price to $20 from $16 previously.
On April 16, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $17 to $15.
On April 10, 2024, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.Canaccord Genuity initiated its Buy rating on April 10, 2024, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 05 ’24 when Melissa Baird bought 16,784 shares for $17.84 per share.
Chi Michael bought 2,054 shares of HIMS for $45,188 on Aug 01 ’24. On Aug 01 ’24, another insider, Chi Michael, who serves as the Chief Commercial Officer of the company, sold 2,054 shares for $22.00 each. As a result, the insider received 45,188 and left with 185,326 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 3872707328 and an Enterprise Value of 3640014848. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.99 while its Price-to-Book (P/B) ratio in mrq is 11.10. Its current Enterprise Value per Revenue stands at 3.794 whereas that against EBITDA is 699.599.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $25.74, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is -15.49%, while the 200-Day Moving Average is calculated to be 35.20%.
Shares Statistics:
The stock has traded on average 11.67M shares per day over the past 3-months and 11178350 shares per day over the last 10 days, according to various share statistics. A total of 205.10M shares are outstanding, with a floating share count of 150.83M. Insiders hold about 29.78% of the company’s shares, while institutions hold 48.55% stake in the company. Shares short for HIMS as of 1721001600 were 19812630 with a Short Ratio of 1.70, compared to 1718323200 on 17003570. Therefore, it implies a Short% of Shares Outstanding of 19812630 and a Short% of Float of 10.5299994.
